Back

Simplify, Personalize, Suppress: Novel Oral ART for HIV Management

This enduring activity aims to improve clinicians knowledge and competence in applying emerging evidence on novel oral ART regimens to optimize individualized, guideline-based management of virologically suppressed HIV infection. As a result of this educational activity, learners will be better able to: 1. Recognize the rationale for novel oral ART regimens in the management of virologically suppressed HIV infection; 2. Review the clinical impact of novel emerging oral ART regimens for patients with virologically suppressed HIV infection; and, 3. Formulate patient-centered strategies for optimizing the personalized management of oral ART for patients with virologically suppressed HIV infection. Learners has access to downloadable materials for future reference.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.5 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Microlearning
  • includes Article / monograph / reference
  • Credit · Up to 0.5 credits
  • Commercial Support
  • Released
    May 22, 2026
  • Last day to claim credit
    May 22, 2027 7 months left